
ARK Genomic Revolution ETF
ARKGBATSARKEquity
As of Nov 16, 2026 close
- Assets (AUM)
- $2.17B
- Expense ratio
- 0.75%
- Dividend yield
- -
- Holdings
- 33
- 52-week range
- $24.60$58.83
- Volume (live)
- -
- Avg. volume (3M)
- 5.81M
ARKG ETF Holdings: ARK Genomic Revolution ETF
The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 32 of 33 ARKG Holdings by Portfolio Weight
Holdings data last updated Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 32 positions.
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Twist Bioscience Corporation | Stock | 10.23% |
| 2 | ![]() | 10x Genomics, Inc. | Stock | 10.04% |
| 3 | ![]() | Tempus AI, Inc. | Stock | 8.51% |
| 4 | ![]() | CRISPR Therapeutics AG | Stock | 6.17% |
| 5 | ![]() | Personalis, Inc | Stock | 5.92% |
| 6 | ![]() | Absci Corporation | Stock | 5.15% |
| 7 | ![]() | Guardant Health, Inc. | Stock | 4.61% |
| 8 | ![]() | Natera, Inc. | Stock | 4.57% |
| 9 | ![]() | CareDx, Inc. | Stock | 4.51% |
| 10 | ![]() | Illumina, Inc. | Stock | 4.45% |
| 11 | ![]() | Eli Lilly and Company | Stock | 4.12% |
| 12 | ![]() | Beam Therapeutics Inc | Stock | 3.41% |
| 13 | ![]() | COMPASS Pathways plc | Stock | 3.21% |
| 14 | ![]() | Schrödinger, Inc. | Stock | 3.10% |
| 15 | ![]() | Recursion Pharmaceuticals, Inc. | Stock | 2.58% |
| 16 | ![]() | Nurix Therapeutics, Inc | Stock | 2.37% |
| 17 | ![]() | Adaptive Biotechnologies Corporation | Stock | 2.35% |
| 18 | ![]() | Butterfly Network, Inc | Stock | 2.28% |
| 19 | ![]() | GeneDx Holdings Corp. | Stock | 2.15% |
| 20 | ![]() | Veracyte, Inc. | Stock | 2.11% |
| 21 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 1.79% |
| 22 | ![]() | Intellia Therapeutics, Inc | Stock | 1.73% |
| 23 | ![]() | Alamar Biosciences, Inc. Common Stock | Stock | 1.73% |
| 24 | ![]() | Arcturus Therapeutics Holdings Inc. | Stock | 1.69% |
| 25 | ![]() | Prime Medicine Inc. Common Stock | Stock | 1.27% |
| 26 | ![]() | Pacific Biosciences of California, Inc. | Stock | 1.24% |
| 27 | ![]() | Cerus Corporation | Stock | 1.09% |
| 28 | ![]() | Generate Biomedicines, Inc. Common Stock | Stock | 1.03% |
| 29 | ![]() | 908 Devices Inc | Stock | 1.03% |
| 30 | SCTX | Scribe Therapeutics Inc. Common Stock | Stock | 0.64% |
| 31 | FRNM | Freenome, Inc. Common stock | Stock | 0.48% |
| 32 | ![]() | Quantum-Si incorporated | Stock | 0.27% |
Source: Fund holdings disclosures. Last updated Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About ARK Genomic Revolution ETF Holdings
What are the top holdings in ARKG?
In holdings data last updated Oct 4, 2026, ARKG's largest holdings are Twist Bioscience Corporation (TWST) at 10.23%, 10x Genomics, Inc. (TXG) at 10.04%, Tempus AI, Inc. (TEM) at 8.51%, CRISPR Therapeutics AG (CRSP) at 6.17% and Personalis, Inc (PSNL) at 5.92%. Together these 5 positions make up 40.9% of the fund. ARKG holds 33 securities in all; the holdings data lists the top 32 by weight.
How concentrated is ARKG's portfolio?
In holdings data last updated Oct 4, 2026, the 10 largest of ARKG's 33 positions make up 64.2% of assets. The largest single position is Twist Bioscience Corporation (TWST) at 10.23%. The other 1 holdings are not itemized in the source data. Its largest sector, Healthcare, is 100.0% of the portfolio.
What is ARKG's sector allocation?
In holdings data last updated Oct 4, 2026, ARKG's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.
What countries does ARKG invest in?
In holdings data last updated Oct 4, 2026, 90.8% of ARKG's portfolio is invested in the United States, followed by Switzerland (8.1%) and the United Kingdom (1.1%). ARKG has exposure to 3 countries in total. By asset type the fund is 99.4% stocks and 0.6% cash.





























